7. STOCK OPTIONS AND WARRANTS

9 Months Ended

Sep. 30, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Options

There were no options outstanding and exercisable as of September 30, 2013.

Warrants

At September 30, 2013, warrants shares outstanding were as follows:

	Shares		Weighted Average Exercise Price
Balance at December 31, 2012		10,295,500	$	0.44
Granted		–		–
Exercised		–		–
Expired		–		–
Balance at September 30, 2013		10,295,500	$	0.44

The following table summarizes information about stock warrants outstanding and exercisable as of September 30, 2013:

		Warrants Outstanding							Warrants Exercisable
Range of Exercise Prices		Number of Shares Underlying Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Number of Shares		Weighted Average Exercise Price
$	0.40		8,745,500	(i)	$	0.40		2.00		8,745,500	$	0.40
$	0.64		1,500,000		$	0.64		2.25		1,500,000	$	0.64
$	1.00		50,000		$	1.00		1.25		50,000	$	1.00
			10,295,500							10,295,500

As of September 30, 2013, there was no intrinsic value of the warrants outstanding and exercisable

(i) As of September 30, 2013, agreements governing 1,843,000 of the warrants exercisable at $0.40 per share include an anti-dilution provision that allows for the automatic reset of the exercise price upon any future sale of the Company’s common stock, warrants, options, convertible debt or any other equity-linked securities at an issuance, exercise or conversion price below the exercise price of these warrants.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References+ Details

BALQON CORP. 10-Q